These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7502795)

  • 1. Exploitation of the whole gut lavage technique for in vivo assessment of intestinal immunity and inflammation in inflammatory bowel disease.
    Ferguson A; Choudari CP; Mwantembe O; Handy L
    Adv Exp Med Biol; 1995; 371B():1257-60. PubMed ID: 7502795
    [No Abstract]   [Full Text] [Related]  

  • 2. P-ANCA as a differential diagnostic marker in inflammatory bowel disease.
    Oberstadt K; Schaedel W; Weber M; Classen M; Deusch K
    Adv Exp Med Biol; 1995; 371B():1313-6. PubMed ID: 7502807
    [No Abstract]   [Full Text] [Related]  

  • 3. [Polygenetic disturbance in the front line mucosa defense].
    Söderholm JD; Pettersson S
    Lakartidningen; 2009 Nov 4-12; 106(45):2974, 2976-8. PubMed ID: 19998821
    [No Abstract]   [Full Text] [Related]  

  • 4. T cell apoptosis and inflammatory bowel disease.
    Peppelenbosch MP; van Deventer SJ
    Gut; 2004 Nov; 53(11):1556-8. PubMed ID: 15479669
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease.
    Torres MI; Le Discorde M; Lorite P; Ríos A; Gassull MA; Gil A; Maldonado J; Dausset J; Carosella ED
    Int Immunol; 2004 Apr; 16(4):579-83. PubMed ID: 15039388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin subclass distribution of anti-LPS antibody-secreting cells of colonic mucosa from patients with inflammatory bowel disease.
    Arashi M; Konno K; Yachi A
    Adv Exp Med Biol; 1995; 371B():1277-80. PubMed ID: 7502799
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution and density of TNF immunoreactivity in chronic inflammatory bowel disease.
    Murch SH; Braegger CP; Walker-Smith JA; MacDonald TT
    Adv Exp Med Biol; 1995; 371B():1327-30. PubMed ID: 7502810
    [No Abstract]   [Full Text] [Related]  

  • 8. Sarcoidosis and inflammatory bowel disease.
    Storch I; Rosoff L; Katz S
    J Clin Gastroenterol; 2001 Oct; 33(4):345. PubMed ID: 11588558
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon alpha-2A (roferon) as a treatment of inflammatory bowel disease in children and adolescents.
    Hadziselimovic F; Schaub U; Emmons LR
    Adv Exp Med Biol; 1995; 371B():1323-6. PubMed ID: 7502809
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum antibodies for the diagnosis of inflammatory bowel disease: ANCA for ulcerative colitis and ASCA for Crohn's disease.
    Tecnologica MAP Suppl; 1999 Jun; ():18-20. PubMed ID: 10848041
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease.
    Miyoshi E; Shinzaki S; Fujii H; Iijima H; Kamada Y; Takehara T
    Proteomics Clin Appl; 2016 Apr; 10(4):384-90. PubMed ID: 26427763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease.
    Statter MB; Hirschl RB; Coran AC
    Pediatr Clin North Am; 1993 Dec; 40(6):1213-31. PubMed ID: 8255623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a regulatory "defect" for CD4 positive intestinal T cells in vitro in patients with IBD compared to normals.
    Niessner M; Gerok W; Volk BA
    Adv Exp Med Biol; 1995; 371B():1267-71. PubMed ID: 7502797
    [No Abstract]   [Full Text] [Related]  

  • 14. The incidence of colonic natural killer cells, large granular lymphocytes and mast cells in inflammatory bowel disease.
    Emmons LR; Schaub U; Hadziselimovic F
    Adv Exp Med Biol; 1995; 371B():1261-6. PubMed ID: 7502796
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunopathogenesis of inflammatory bowel disease: role of cytokines and immune cell-enterocyte interactions.
    Dionne S; Ruemmele FM; Seidman EG
    Nestle Nutr Workshop Ser Clin Perform Programme; 1999; 2():41-57; discussion 58-61. PubMed ID: 11490627
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunology of inflammatory bowel disease.
    MacKechnie HL
    Henry Ford Hosp Med J; 1982; 30(1):25-32. PubMed ID: 6123493
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease.
    Rovedatti L; Kudo T; Biancheri P; Sarra M; Knowles CH; Rampton DS; Corazza GR; Monteleone G; Di Sabatino A; Macdonald TT
    Gut; 2009 Dec; 58(12):1629-36. PubMed ID: 19740775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of colonoscopy in patients with chronic inflammatory intestinal diseases. German Society of Digestive and Metabolic Diseases].
    Ewe K
    Z Gastroenterol; 1993 Oct; 31(10):639-42. PubMed ID: 8256483
    [No Abstract]   [Full Text] [Related]  

  • 19. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut lavage fluid proteins as markers of activity of inflammatory bowel disease.
    O'Mahony S; Choudari CP; Barton JR; Walker S; Ferguson A
    Scand J Gastroenterol; 1991 Sep; 26(9):940-4. PubMed ID: 1947786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.